학술논문

Effects of the SGLT2 Inhibitor Dapagliflozin on Epicardial and Visceral Fat in Patients With Type 2 Diabetes and Metabolic Syndrome: a Randomized Controlled Trial
Document Type
Journal
Source
CIRCULATION; NOV 14 2017, 136 2p. Supplement: 1
Subject
Language
English
ISSN
15244539